Financing, Equity Capital Markets

Oyster Point Pharma, Inc.

05/20
|
$120.8 Million
Piper Sandler served as bookrunner for Oyster Point Pharma, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma